Nano-X Imaging Ltd, a start-up founded by Israeli investor Ran Poliakine, is joining forces with South Korean chipmaker SK Hynix Inc to build a machine that could disrupt a century-old X-ray industry.
Valued at about US$2 billion after listing on the NASDAQ last month, Nano-X is seeking to transform a multibillion-dollar industry that has essentially relied on the same technology since Nobel Prize in Physics winner Wilhelm Roentgen discovered X-rays in the late 19th century.
Nano-X’s device uses semiconductors instead of metal filaments to generate X-rays.
The backing of SK Hynix, the world’s second-largest maker of memory chips, is a boost for an eight-year-old outfit that has not quite established its tech bona fides yet. It also reflects growing technology cooperation between Israel and South Korea, two nations that have helped shape the global economy by advancing innovations and taking big risks.
Nano-X stock has more than doubled in the weeks since its listing, even before it has revenue or regulatory approvals.
That speaks to market excitement about the company, but has fanned skepticism among people who have seen companies such as Theranos Inc fall apart when their visions were not fulfilled.
“I realize there are skeptics,” Poliakine said in an interview at the Seoul office of private equity backer The Yozma Group. “This is a promise, but it wouldn’t have been a promise if there were not a huge risk.”
At the heart of that promise is a donut-shaped scanner dubbed Nanox.ARC, which uses semiconductors to digitally calibrate the intensity of beams to capture layers of human organs instantly, without having to reach intense temperatures or rotate like a conventional computerized tomography (CT) scanner, according to the company.
Nano-X says that its devices not only generate less radiation, but are far cheaper to make because they do away with large cooling systems and other bulky components.
It says the devices would be given away if clients agree to a pay-per-scan plan.
If it really can reduce radiation, improve images and provide access for more patients, while saving money for doctors, the machine has the potential to be “very disruptive,” said David Smith, associate professor of clinical radiology at Louisiana State University’s Health Sciences Center and University Medical Center in New Orleans.
“If it fails in any of those things, it may not be disruptive, but it may fill a niche market,” Smith added.
With much of the world lacking access to diagnostic imaging, Nano-X says that it has deals to supply about 4,500 units in more than a dozen countries, and plans mass production with the help of iPhone manufacturer Hon Hai Precision Industry Co Ltd (鴻海精密), known internationally as Foxconn Technology Group (富士康科技集團).
Its success heavily depends on securing regulatory approval from each nation where it operates, including the US Food and Drug Administration (FDA), which this year has been focused on the fight against the COVID-19 pandemic.
The company has submitted applications for FDA approval, a process expected to take months. Poliakine said that he is “very confident” Nano-X would get such clearance.
Another hurdle is operational — the ability to sell and distribute Nano-X units across the world when the company still has only dozens of employees, said Poliakine, who called the expansion process “a big headache.”
Nano-X targets “neighborhood clinics” such as urgent-care centers found across the US, rather than the high-end CT-scan market, he said.
Those smaller facilities cater to patients with broken bones, internal bleeding or other illnesses requiring immediate care, but often cannot afford the kind of scanning devices that bigger hospitals have.
“They don’t have the equipment, money, and there’s not enough data or algorithms to sort out the noise from signals,” Poliakine said.
The clinics would consult with Nano-X radiologists via the cloud.
Images could even be scanned in ambulances or helicopters, but that would require high-speed wireless connections, which SK Telecom Co, South Korea’s biggest carrier, aims to support.
The Seoul-based firm has invested US$23 million in Nano-X and seeks to provide some of the artificial intelligence technology that would analyze medical images and reduce the chance of mis-diagnosis.
Applications could go beyond medicine, helping enable more thorough inspections in South Korea’s manufacturing industries, said Irene Kim, a spokeswoman for SK Telecom.
SK Telecom’s subsidiary, SK Hynix, is supporting Nano-X in enhancing the nano-technology behind the semiconductors.
Poliakine visited South Korea this month to explore a site for a joint chip fabrication plant.
POOR INTERNAL CONTROLS: Insurance Bureau Director-General Shih Chiung-hwa said the company is expected to get back on track while its chairman is suspended The Financial Supervisory Commission (FSC) yesterday fined Shin Kong Life Insurance Co (新光人壽) NT$27.6 million (US$939,415) for a reckless investment that endangered its solvency, and suspended its chairman Eugene Wu (吳東進) for poor supervision. The penalty is the second-highest in a single case after Nan Shan Life Insurance Co (南山人壽) was fined NT$30 million in September last year and its chairman Du Ying-tzyong (杜英宗) suspended for two years, the commission said. In three rounds of special and regular examinations conducted since last year, the commission found that Shin Kong Life had given too much power to an asset and liability management committee
Tesla Inc is planning to ship vehicles made at its Shanghai Gigafactory to other markets in Asia and Europe, people familiar with the matter said, as the company looks to realize its plan to reduce shipping costs and manufacture vehicles closer to customers. China-built Tesla Model 3s intended for delivery outside China would likely start mass production in the fourth quarter of the year, the people said, asking not to be identified because the details are private. They said the markets targeted include Singapore, Australia and New Zealand, as well as Europe, where customers currently have to wait for a Tesla to
Nano-X Imaging Ltd, a start-up founded by Israeli investor Ran Poliakine, is joining forces with South Korean chipmaker SK Hynix Inc to build a machine that could disrupt a century-old X-ray industry. Valued at about US$2 billion after listing on the NASDAQ last month, Nano-X is seeking to transform a multibillion-dollar industry that has essentially relied on the same technology since Nobel Prize in Physics winner Wilhelm Roentgen discovered X-rays in the late 19th century. Nano-X’s device uses semiconductors instead of metal filaments to generate X-rays. The backing of SK Hynix, the world’s second-largest maker of memory chips, is a boost for
Continental AG, which makes control units for Daimler AG cars, cannot pursue antitrust claims against a group of patent owners, including Qualcomm Inc, which are seeking royalties on telecommunications technology, a federal judge in Texas ruled. Avanci LLC, a licensing pool formed by Qualcomm, Nokia Oyj, Sharp Corp and other owners of patents on technology standards, is not breaching antitrust laws when it negotiates license agreements with automakers rather than the component makers, Barbara Lynn, chief district judge for the Northern District of Texas, said in dismissing the suit in a decision posted on Friday. The licensing group charges US$15 per vehicle